Home›Compare›Oak Longevity vs Remedy Meds

Oak Longevity vs Remedy Meds: Which Is Better?

Head-to-head comparison of Oak Longevity and Remedy Meds based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

Remedy Meds scores higher overall in our independent evaluation (69/100 vs 60.3/100), leading on trust & safety, value, experience, reputation. Oak Longevity comes out ahead on product range. Oak Longevity has the lower entry price (from $79/mo vs $189/mo), so the better value depends on which treatment you need.

Oak Longevity ('Oak Loves You') is a small cash-pay telehealth brand selling compounded GLP-1s, ED medication and NAD+/sermorelin. Headline prices require multi-month plans, and orders become non-refundable once sent to the pharmacy.

Visit Oak Longevity

Fast-growing GLP-1 telehealth platform with flat dose-agnostic pricing and bundled labs; owner of Keeps, Nurx, and Cove via its $500M Thirty Madison acquisition.

Visit Remedy Meds

Score Breakdown

DimensionOak LongevityRemedy Meds
Overall Score60.3/10069/100 ✓
Trust & Safety30%55/10065/100 ✓
Value25%66/10080/100 ✓
Experience20%64/10072/100 ✓
Product Range15%62/100 ✓58/100
Reputation10%52/10064/100 ✓

At a Glance

Founded20242024
Headquarters—Summit, NJ
Publicly tradedNoNo
Treatment categories31
Treatments listed53
Starting price$79/mo$189/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryOak LongevityRemedy Meds
Weight Loss / GLP-1$130–$235
Compounded Semaglutide
$189
GLP-1 Microdose Plan

Oak Longevity

+Compounded semaglutide from about $130/mo on multi-month plans, flat across doses
+Positive Trustpilot base (4.4/5, 54 reviews) citing fast approvals and responsive messaging
+Range spans GLP-1s, ED (tadalafil), NAD+ and sermorelin under one account
−Homepage 'from $89/mo' pricing is well below the ~$235/mo (semaglutide) and ~$285/mo (tirzepatide) one-month checkout prices
−Orders become non-refundable once sent to the pharmacy; mandatory arbitration and class-action waiver
−Opaque structure: three legal entity names, a Vancouver, BC BBB registration, and unnamed pharmacies and leadership
Read the full Oak Longevity review →

Remedy Meds

+Flat, dose-agnostic pricing — monthly cost doesn't increase as GLP-1 dose titrates up
+Comprehensive inclusions: lab work, unlimited video visits, meal plans, and shipping bundled
+Strong scale: 250,000+ members, 1.2M+ prescriptions, 94.6% reported success rate
−Owns Nurx and Keeps through the Thirty Madison acquisition completed in late 2025, so all three appear separately in this index but share an owner
−The weight-loss guarantee refunds membership fees only after twelve unbroken months and is voided by any pause; the help centre also states payments are non-refundable once processed
−Removed all public pricing between March and June 2026; the price display still exists in the site's code but ships switched off, so a figure is only quoted after intake
Read the full Remedy Meds review →

Oak Longevity vs Remedy Meds — FAQ

Is Oak Longevity better than Remedy Meds?

▾

Remedy Meds scores higher overall in our independent evaluation (69/100 vs 60.3/100), leading on trust & safety, value, experience, reputation. Oak Longevity comes out ahead on product range. Oak Longevity has the lower entry price (from $79/mo vs $189/mo), so the better value depends on which treatment you need.

Is Oak Longevity or Remedy Meds cheaper?

▾

Oak Longevity has the lower starting price (from $79/mo vs $189/mo for Remedy Meds). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do Oak Longevity and Remedy Meds both offer?

▾

Both platforms treat Weight Loss / GLP-1. Oak Longevity covers 3 treatment categories total and Remedy Meds covers 1.

Still deciding?